The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.
作者信息
Pigott H Edmund
机构信息
Chief Clinical Officer, Positive Brain Training, LLC, Juno Beach, Florida; Psychologist, Guiding Light Wellness Center, Wellington, Florida.
出版信息
Can J Psychiatry. 2015 Jan;60(1):9-13. doi: 10.1177/070674371506000104.
Abstract
摘要
相似文献
1
The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.
Can J Psychiatry. 2015 Jan;60(1):9-13. doi: 10.1177/070674371506000104.
2
STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby!
Can J Psychiatry. 2015 Jan;60(1):6-8. doi: 10.1177/070674371506000103.
3
The value of data on suicidality by treatment arm.
Am J Psychiatry. 2010 Aug;167(8):995; author reply 995-6. doi: 10.1176/appi.ajp.2010.10040468.
4
Placebo group needed for interpretation of combination trial.
Am J Psychiatry. 2010 Aug;167(8):996; author reply 996-7. doi: 10.1176/appi.ajp.2010.10030453.
5
The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.
Can J Psychiatry. 2010 Mar;55(3):126-35. doi: 10.1177/070674371005500303.
7
Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
J Clin Psychopharmacol. 2009 Aug;29(4):411-2; author reply 412. doi: 10.1097/JCP.0b013e3181ace848.
8
Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
Psychother Psychosom. 2012;81(4):226-34. doi: 10.1159/000330890. Epub 2012 May 11.
9
Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
J Clin Psychiatry. 2011 Apr;72(4):464-72. doi: 10.4088/JCP.10m06191.
10
Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
J ECT. 2007 Dec;23(4):244-50. doi: 10.1097/yct.0b013e31814515d6.
引用本文的文献
1
Efficacy and safety of dextromethorphan-bupropion combination (AXS-05) in the treatment of depression: A systematic review and network meta-analysis.
Indian J Pharmacol. 2025 Jul 1;57(4):262-268. doi: 10.4103/ijp.ijp_907_24. Epub 2025 Jul 21.
2
Host-microbiome relationship in depression: can human induced pluripotent stem cells play a role in unravelling mechanisms?
NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):117. doi: 10.1038/s41522-025-00749-z.
3
Public psychology and holistic approaches to prevention and treatment of depression.
Front Psychiatry. 2025 Jun 3;16:1600094. doi: 10.3389/fpsyt.2025.1600094. eCollection 2025.
4
Association Between Polygenic Risk Scores and Treatment Response to Antidepressants, Benzodiazepines, and Antihistamines in Anxiety and Depression.
Biol Psychiatry Glob Open Sci. 2025 Feb 18;5(3):100470. doi: 10.1016/j.bpsgos.2025.100470. eCollection 2025 May.
5
Preferences of patients with depression for exercises: a discrete choice experiment.
BMC Public Health. 2025 Mar 29;25(1):1192. doi: 10.1186/s12889-025-22404-0.
6
Efficacy of a Serotonin-Norepinephrine Reuptake Inhibitor as a Treatment for Meniere Disease: A Randomized Clinical Trial.
JAMA Otolaryngol Head Neck Surg. 2024 Nov 1;150(11):935-942. doi: 10.1001/jamaoto.2024.2241.
7
Influence of aerobic exercise on depression in young people: a meta-analysis.
BMC Psychiatry. 2024 Aug 20;24(1):571. doi: 10.1186/s12888-024-06013-6.
8
Sleep as a predictor of improved response to transcranial magnetic stimulation for depression (SPIRiTeD).
J Affect Disord. 2024 Oct 1;362:9-13. doi: 10.1016/j.jad.2024.06.077. Epub 2024 Jun 27.
9
Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants.
Ann Gen Psychiatry. 2024 May 30;23(1):21. doi: 10.1186/s12991-024-00507-z.
10
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis-The Case of the Xanomeline-Trospium Combination: A Systematic Review.
Pharmaceuticals (Basel). 2024 May 9;17(5):610. doi: 10.3390/ph17050610.
本文引用的文献
1
Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.
J Clin Psychiatry. 2013 Jul;74(7):e14. doi: 10.4088/JCP.12075tx2c.
2
Workplace depression: personalize, partner, or pay the price.
Am J Psychiatry. 2013 Jun;170(6):578-81. doi: 10.1176/appi.ajp.2012.13030382.
3
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Am J Psychiatry. 2013 Jun;170(6):633-41. doi: 10.1176/appi.ajp.2012.12020250.
4
Using algorithms and computerized decision support systems to treat major depression.
J Clin Psychiatry. 2011 Dec;72(12):e36. doi: 10.4088/JCP.10027tx4cc.
5
Measurement-based care for unipolar depression.
Curr Psychiatry Rep. 2011 Dec;13(6):446-58. doi: 10.1007/s11920-011-0237-8.
6
Measurement-based care in psychiatric practice: a policy framework for implementation.
J Clin Psychiatry. 2011 Aug;72(8):1136-43. doi: 10.4088/JCP.10r06282whi. Epub 2011 Jan 11.
7
Efficacy and effectiveness of antidepressants: current status of research.
Psychother Psychosom. 2010;79(5):267-79. doi: 10.1159/000318293. Epub 2010 Jul 9.
8
The STAR*D study: treating depression in the real world.
Cleve Clin J Med. 2008 Jan;75(1):57-66. doi: 10.3949/ccjm.75.1.57.
9
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
CMAJ. 2008 Jan 29;178(3):296-305. doi: 10.1503/cmaj.070693.
10
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
Am J Psychiatry. 2006 Nov;163(11):1905-17. doi: 10.1176/ajp.2006.163.11.1905.
Zotero 插件